LEADER 06061nam 22008295 450 001 9910255277303321 005 20251202152020.0 010 $a3-319-55813-7 024 7 $a10.1007/978-3-319-55813-4 035 $a(CKB)4100000000587804 035 $a(DE-He213)978-3-319-55813-4 035 $a(MiAaPQ)EBC5050566 035 $a(PPN)222235640 035 $a(EXLCZ)994100000000587804 100 $a20170920d2017 u| 0 101 0 $aeng 135 $aurnn|008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAntitrust in Pharmaceutical Markets & Geographical Rules of Origin /$fedited by Pierre Kobel, Pranvera Këllezi, Bruce Kilpatrick 205 $a1st ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017. 215 $a1 online resource (XV, 497 p. 4 illus., 3 illus. in color.) 225 1 $aLIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition,$x2199-7438 311 18$aPrint version: 9783319558127 327 $a Part I: Antitrust in Pharmaceutical Markets: International Report by Stephen Dnes -- Australia by Julie Clarke and Barbora Jedli?ková -- Austria by Gerhard Fussenegger and Rainer Schultes -- Belgium by Koen T?Syen -- Czech Republic by Kamil Nejezchleb -- France by Liliana Eskenazi, Olivier Freget, Laetitia Ghebali, Clément Hubert, Martina Isola, Nizar Lajnef and Jean-Julien Lemonnier -- Hungary by Gusztav Bacher and András Horváth -- India by Arunabha Ganguli -- Italy by Elisa Teti and Ottavia Raffaelli -- Malta by Clement Mifsud-Bonnici -- Poland by Aleksander Stawicki, Paulina Komorowska and Juliusz Krzy?anowski -- Sweden by Vladimir Bastidas Venegas -- Switzerland by Dominique Guex -- The Netherlands by Cees Jan de Boer and Maria Geilmann -- Ukraine by Viktoriia Gladka and Mariia Baranovych.-United Kingdom by James Bourke -- Part II: Geographical Rules of Origin: International Report by Simon Holzer -- Austria by Christoph Petsch and Michael Meyenburg -- Belgium by Claire Hazée -- Brazil by Felipe Barros Oquendo -- France by Guillaume Couet and Martina Isola -- Germany by Olaf Sosnitza -- Hungary by Ádám Liber -- Japan by Noriko Itai, Kenta Sugimoto and Shigeshi Tanaka -- Malta by Philip Mifsud and Elise Dingli -- Poland by Aleksandra W?drychowska-Karpi?ska and Agnieszka Wierci?ska-Kru?ewska. 330 $aThis book gathers international and national reports from across the globe on key questions in the field of antitrust and intellectual property. The first part discusses the application of competition law in the pharmaceutical sector, which continues to be a focus for anti-trust authorities around the world. A detailed international report explores the extent to which the application of the competition rules in the pharmaceutical sector should be affected by the specific characteristics of those products and markets (including consumer protection rules, the need to promote innovation, the need to protect public budgets, and other public interest considerations). It provides an excellent comparative study of this complex subject, which lies at the interface between competition law and intellectual property law. The second part of the book gathers contributions from various jurisdictions on the topic of ?What rules should govern claims by suppliers about thenational or geographic origin of their goods or services?? This section presents an international report, which offers an unparalleled comparative analysis of this topic, bringing together common themes and contrasting the various national provisions dealing with indications of origin, amongst other things. The book also includes the resolutions passed by the General Assembly of the International League of Competition Law (LIDC) following a debate on each of these topics, which include proposed solutions and recommendations. The LIDC is a long-standing international association that focuses on the interface between competition law and intellectual property law, including unfair competition issues. 410 0$aLIDC Contributions on Antitrust Law, Intellectual Property and Unfair Competition,$x2199-7438 606 $aInformation technology$xLaw and legislation 606 $aMass media$xLaw and legislation 606 $aPharmacology 606 $aInternational law 606 $aTrade regulation 606 $aPrivate international law 606 $aConflict of laws 606 $aComparative law 606 $aMedical laws and legislation 606 $aCommercial law 606 $aIT Law, Media Law, Intellectual Property 606 $aPharmacology 606 $aInternational Economic Law, Trade Law 606 $aPrivate International Law, International and Foreign Law, Comparative Law 606 $aMedical Law 606 $aBusiness Law 615 0$aInformation technology$xLaw and legislation. 615 0$aMass media$xLaw and legislation. 615 0$aPharmacology. 615 0$aInternational law. 615 0$aTrade regulation. 615 0$aPrivate international law. 615 0$aConflict of laws. 615 0$aComparative law. 615 0$aMedical laws and legislation. 615 0$aCommercial law. 615 14$aIT Law, Media Law, Intellectual Property. 615 24$aPharmacology. 615 24$aInternational Economic Law, Trade Law. 615 24$aPrivate International Law, International and Foreign Law, Comparative Law. 615 24$aMedical Law. 615 24$aBusiness Law. 676 $a344.04233 702 $aKobel$b Pierre$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aKëllezi$b Pranvera$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aKilpatrick$b Bruce$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910255277303321 996 $aAntitrust in Pharmaceutical Markets & Geographical Rules of Origin$91971497 997 $aUNINA